adavosertib discontinued - SERP Analysis

https://www.targetedonc.com/view/adavosertib-active-in-uterine-cancer-but-tolerability-limits-use

https://www.onclive.com/view/exploiting-the-vulnerabilities-of-high-grade-serous-ovarian-cancer-through-wee1-inhibition

https://ascopost.com/issues/may-25-2023/poor-tolerability-appears-to-hinder-benefit-of-adavosertib-in-uterine-serous-carcinoma/

https://www.fiercebiotech.com/biotech/astrazeneca-axes-moderna-partnered-phase-2-heart-disease-drug-amid-other-wee-pipeline

https://www.oncnursingnews.com/view/adavosertib-yields-preliminary-safety-concerns-antitumor-activity-in-usc

https://aacrjournals.org/cancerrescommun/article/4/7/1793/746640/A-Phase-II-Trial-of-the-WEE1-Inhibitor-Adavosertib

https://www.nature.com/articles/d42473-024-00266-1

https://pmc.ncbi.nlm.nih.gov/articles/PMC10326086/

https://ascopubs.org/doi/10.1200/JCO-24-01606

https://www.oncologypipeline.com/apexonco/zentalis-doubles-down-wee1

https://www.sciencedirect.com/science/article/pii/S2468294224000212

https://pubmed.ncbi.nlm.nih.gov/40262070/

https://adisinsight.springer.com/drugs/800028808

https://www.onclive.com/view/adavosertib-shows-early-antitumor-activity-despite-safety-concerns-in-uterine-serous-carcinoma

https://www.oncologypipeline.com/apexonco/can-wee1-be-both-alive-and-dead-schrodinger-hopes-so

https://www.sciencedirect.com/science/article/pii/S1048891X24005644

https://www.ajmc.com/view/recent-adavosertib-results-in-ovarian-cancer-could-be-sign-of-things-to-come

https://clinicaltrials.gov/study/NCT02617277

https://www.cancertherapyadvisor.com/reports/adavosertib-uterine-cancer-advanced-active-toxic/

https://www.dana-farber.org/clinical-trials/18-316

https://aacrjournals.org/clincancerres/article/28/1/36/675030/Adavosertib-with-Chemotherapy-in-Patients-with

https://www.valuebasedcancer.com/issues/2020/august-2020-vol-11-no-4/the-wee1-inhibitor-adavosertib-displays-promising-clinical-activity-in-uterine-serous-cancer

https://link.springer.com/article/10.1007/s10637-023-01371-6

https://www.dana-farber.org/clinical-trials/19-059

https://ascopubs.org/doi/10.1200/JCO.2022.40.16_suppl.5515

https://www.astrazeneca.com/our-therapy-areas/pipeline.html

https://en.wikipedia.org/wiki/Adavosertib

https://en.wikipedia.org/wiki/Protein_kinase_inhibitor

https://endpoints.news/after-nearly-a-decade-of-work-astrazeneca-axes-wee1-and-culls-moderna-partnered-drug/

https://ascopost.com/news/may-2025/adavosertib-in-recurrent-or-persistent-uterine-serous-carcinoma/